Hydralazine Hydrochloride
NDC 51079-074, Hydralazine Hydrochloride, tablet, from Mylan Institutional Inc..
- Product NDC
- 51079-074
- Status
- Listed
- Labeler
- Mylan Institutional Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA089097
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51079-074 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- HYDRALAZINE HYDROCHLORIDE10 mg/1
Pharmacologic classes
Arteriolar Vasodilation [PE]; Arteriolar Vasodilator [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51079-074-20 | 51079007420 | 100 BLISTER PACK in 1 CARTON (51079-074-20) / 1 TABLET in 1 BLISTER PACK (51079-074-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/493a8b7e-5bb1-4db2-91a7-77ed87864131NADAC price for package 51079007420
GET /v1/drugs/nadac/51079007420
Use it
Look up 51079-074 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51079-074 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51079-074. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.